NCT01551173View on ClinicalTrials.gov

Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

PHASE4CompletedINTERVENTIONAL
Enrollment

436

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Lipid Metabolism Disorders
Interventions
DRUG

Fluvastatin sodium

Fluvastatin sodium Extended Release Tablets 80mg

Trial Locations (1)

410011

Novartis Investigative Site, Changsha

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY